ARHGAP39 and breast carcinoma: Under the condition of relative expression level, we knocked down ARHGAP39 by introducing two independent specific siRNAs in MDA-MB-231 and CAL51 breast cancer cells, followed by qRT-PCR analysis (Fig. 2D-E).